Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement
暂无分享,去创建一个
M. Sajadi | P. Kwong | Y. Kwon | M. Seaman | P. Lusso | A. Devico | Mohammad M. Sajadi | Yin Lin | H. Miao | Qingbo Liu | Peng Zhang | Zahra Rikhtegaran-Tehrani
[1] Mitchell Ho,et al. COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19 , 2020, Antibody therapeutics.
[2] N. Garrett,et al. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review , 2020, The Journal of infectious diseases.
[3] B. Korber,et al. Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention. , 2020, Annual review of immunology.
[4] L. Corey,et al. Broadly Neutralizing Antibodies for HIV Prevention. , 2020, Annual review of medicine.
[5] J. Bloom,et al. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody , 2020, Cell.
[6] T. Chun,et al. Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles. , 2019, JAMA.
[7] J. Mascola,et al. Improvement of antibody functionality by structure-guided paratope engraftment , 2019, Nature Communications.
[8] F. Klein,et al. Antibody-mediated prevention and treatment of HIV-1 infection , 2018, Retrovirology.
[9] J. Tartaglia,et al. Faculty Opinions recommendation of Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[10] G. Cavet,et al. Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses , 2018, Cell.
[11] Haniye Sadat Sajadi,et al. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015 , 2018, The Lancet.
[12] J. Mascola,et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 , 2018, bioRxiv.
[13] J. Mascola,et al. Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody , 2018, Cell reports.
[14] G. Chuang,et al. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer , 2017, Nature Structural &Molecular Biology.
[15] Tongqing Zhou,et al. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth. , 2016, Immunity.
[16] Young Do Kwon,et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G , 2016, Cell.
[17] Cinque S. Soto,et al. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors , 2015, Cell.
[18] Young Do Kwon,et al. Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo , 2014, Journal of Virology.
[19] J. Mascola,et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection , 2014, Nature.
[20] Ron Diskin,et al. Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design , 2011, Science.
[21] Ron Diskin,et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.